Novelty and impact of our paper: This paper investigated in detail family history of cancer in children with leukemia and lymphoma in France at a national scale. We report that cancers were more frequent in the first and second-degree relatives of lymphoma cases than in population controls, and the associations were stronger for a family history of Hodgkin's lymphoma.
Introduction
Specific genetic syndromes play a role in the etiology of only a very small proportion of hematopoietic malignancies in children 1, 2 . The syndromes include familial neoplastic syndromes, inherited immunodeficiency and bone marrow failure syndromes 1 . The potential role of inherited susceptibility in childhood acute leukemia and lymphoma has yet to be elucidated. Large population-based registry-linked studies have investigated the familial aggregation of Hodgkin's lymphoma, non-Hodgkin's lymphoma or leukemia [3] [4] [5] [6] [7] . In children, few population-based registry-linked studies have been published [8] [9] [10] [11] [12] [13] , most of them relating to first-degree relatives [8] [9] [10] [11] [12] . The estimated relative risks for a positive family history of cancer ranged from 0.8 to 1.0 for childhood leukemia 8, [10] [11] [12] [13] and from 1.0 to 1.8 for childhood lymphoma taken as a whole 8, [10] [11] [12] . A number of case-control studies have addressed the association between history of cancer in first and second degree relatives of children with leukemia and observed OR from 1.1 to 1.6 [14] [15] [16] [17] [18] . Only one case-control study has been published for childhood Hodgkin's lymphoma and non-Hodgkin's lymphoma 15 . Overall the number of published studies in children is weak, particularly for lymphomas. The aim of the present study was to investigate the association between childhood acute leukemia (AL),
Hodgkin's lymphoma (HL) and non-Hodgkin's lymphoma (NHL) and a family history of cancer in the first-and second-degree relatives of the index children.
Patient and methods
The ESCALE study was a French national population-based case-control study conducted in 2003 and 2004 to investigate the role of infectious, environmental and genetic factors in four childhood neoplastic diseases. The present paper focuses on acute leukemia (AL),
Hodgkin's lymphoma (HL) and non-Hodgkin's lymphoma (NHL).
Case and control ascertainment
The cases were identified directly by the investigators assigned to each French pediatric oncology hospital department, with the support of the French National Registry of Childhood Blood Malignancies 19 . In order for the cases to be eligible, leukemia or lymphoma was to have been newly diagnosed between January 1, 2003, and December 31, 2004. The cases were also required to be aged less than 15 years and resident in France at the time of diagnosis. Cases who had been adopted, or whose biological mother had died, or whose mother did not speak French or whose mother presented with a psychiatric disorder were not The participation rates were 91, 86 and 88% for acute leukemia, Hodgkin's lymphoma and non-Hodgkin's lymphoma, respectively.
The controls were randomly selected from the French population using a quota sampling method. A first sample of 60,000 addresses representative of the French population in terms of region and degree of urbanization was constituted from the French national telephone directory (plus randomly generated unlisted numbers). The quotas were designed to make the controls similar to all the cases of all types of cancer in term of age and gender, using the French National Registry of Childhood Blood Malignancies 19 and the Regional Childhood cancer Registries 20 as reference. Additional quotas were used to ensure that the control group was also representative of the French general population in terms of the number of children aged under 15 years living in the household, conditionally on age, based on the 1999 population census. Like the cases, the controls were not to have been adopted and were to have a biological mother who could be interviewed (alive, not presenting with a serious psychiatric disorder and French-speaking).
Out of the 50,217 phone numbers dialed, 22,584 did not connect to a home number, 24, 410 were ineligible, and, for 862, the respondent hung up before eligibility could be checked. For the 2,361 remaining numbers, there were 679 refusals to participate. Thus, 1,682 mothers were interviewed (71.2%). One control with a history of neuroblastoma was excluded and 1681 children were included as controls.
Data collection
The telephone interviews with the cases' and controls' biological mothers were carried out by the same trained interviewers using structured questionnaires. The cases' mothers were interviewed at least 2 months after the diagnosis. 20 anaplastic large cell, 37 B-cell lymphoblastic and 27 T-cell lymphoblastic, and 5 unspecified NHL).
Case and control comparability
The distribution of the cases and controls by the quota variable combining age and gender is shown in table 1. The cases and controls were similar with respect to that variable for the study as a whole, but not for each hematopoietic malignancy. In particular, the lymphoma cases were significantly older than the controls. All the strata contained more than one control per case for adjustment, with more controls per lymphoma case in the youngest strata. The controls' parents were slightly more educated and had a higher professional status than the parents of the leukemia and Hodgkin's lymphoma cases (table 2) . There was no significant difference between the cases and controls in terms of the mothers' or grandparents' ages and the number of family members, after controlling for child age and gender.
Consanguinity within first and second degree relatives was observed in none of the cases or controls.
Family history of cancer
The ORs associated with a positive family history of cancer in first-degree relatives, second- reported for 42% of the acute leukemia, 61% of the Hodgkin's lymphoma and 61% of the non-Hodgkin's lymphoma cases and 42% of the controls. For each childhood hematopoietic malignancy, the ORs were higher when at least two relatives had had a cancer or when at least one family member had experienced a malignancy before age 46 years. The ORs associated with a history of malignancy in a paternal relative were higher than those for a history of malignancy in a maternal relative for acute leukemia, but not for either type of lymphoma. Table 4 shows the results by disease site and group of sites. A family history of The results were unchanged after exclusion of the children with Down's syndrome. The use of polytomous logistic regression models for ALL and AML, for AL and NHL (restricted to age greater than or equal to 2 years), and for AL, HL and NHL (restricted to age greater than or equal to 5 years) did not alter the results. With regard to potential confounders, no variable was statistically significantly associated with both a childhood hematopoietic malignancy and a family history of cancer, after controlling for child age and gender. Neither parental professional category nor educational level was associated with a family history of cancer in the control group. The results were also unchanged when the analyses were adjusted for familial structure (mother's and father's ages, mean ages of grand-parents and of uncles and aunts, number of relatives), socioeconomic status (professional category, educational level, degree of urbanization of the place of residence), breast-feeding and early infections, which have been previously shown to be related to leukemia in the literature and were also related in this study 21 . The results were unchanged after exclusion of the children who had at least one grandparent born in Africa or Asia.
Discussion
A positive association with a family history of cancer was observed for non-Hodgkin's lymphoma and Hodgkin's lymphoma, but not for acute leukemia. Only Hodgkin's lymphoma was associated with a positive family history of hematopoietic malignancy, mainly due to the high OR for family history of Hodgkin's lymphoma. Significant positive associations were also observed with a family history of solid tumor in the following disease sites: colon/rectum/anus with Hodgkin's and non-Hodgkin's lymphoma; uterine/ovarian with non-Hodgkin's lymphoma and acute leukemia; and testicular and pancreas with non-Hodgkin's lymphoma. The numbers were too small to allow the analysis of leukemia or lymphoma aggregation separately for the first and second degrees.
Genetic susceptibility could be reflected by an increased familial incidence and earlier onset of malignancies. Indeed, for lymphoma, the ORs were higher when at least two relatives had presented with cancer or when the age at diagnosis of a single case was less than 46 years.
This tendency was also observed, at a lesser extent, for leukemia; a weak genetic susceptibility to leukemia cannot be then excluded with regard to our results.
With an alpha error of 5%, the statistical power of the study to evidence an OR of 1.5, which was the order of magnitude of the relationship between childhood AL and family history of cancer in three previous case-control studies [15] [16] [17] , was greater than 99%.
The relatives were quite young: the mean age of the parents at the time of the interview was about 40 years; that of the grand-parents about 65 years. A lack of statistical power for specific types of cancer with a high age of onset is therefore probable. The positive results for cancers with lower ages of onset were less censored.
The cases were identified through the data collection system of the French National Registry of Childhood Blood Malignancies, making case selection at the identification stage unlikely.
Cases who had died or were receiving palliative care (41 AL, 3 HL and 7 NHL) were not eligible. However, the absence of a relationship between leukemia and family history of cancer is unlikely to result from a survival bias. The severity of leukemia is not known to be related to family history, and, in the present study, the leukemia cases who died during the year following the telephone interview had an even less frequently positive family history of Malignancies. Therefore, a selection by survival of cases related to these familial rare diseases is unlikely.
The controls were randomly selected from the overall population. The national telephone directory was used as the basis for random selection. Selection of controls with listed numbers only was avoided by randomly generating unlisted numbers. There were no differences between the cases and controls with regard to gender or age (considering all types of cancer), or between the controls and overall population with regard to birth order.
The quota recruitment process was thus successful. The refusals to take part could have been related to the parental socioeconomic status or educational level which appeared higher among controls than among Hodgkin's lymphoma and, to a lesser extent, leukemia cases. The control mothers educational levels were very similar to those of the French population, but the control fathers' educational levels were higher [22] [23] [24] . However, parental socioeconomic status and educational level were not associated with a family history of cancer in the control group and the results were unchanged after adjustment for these variables. We collected no direct information on ethnicity, which might be related to the risk of childhood cancer and to history of cancer in relatives. However, excluding the children whose any grand-parent was born in Africa or Asia had no influence on the results.
Non-differential misclassification bias was probable since the cancer history data only consisted in the mothers' reports. However, bias was limited by the use of specific closed questions and by the fact that the mothers were asked about her and the father's close family, i.e. children, siblings and parents. Adults with cancer have been shown to report their family history of cancer in first degree relatives quite accurately [25] [26] [27] [28] [29] [30] [31] [32] [33] . . To our knowledge, no study of accuracy with respect to children has been conducted.
Misclassification may be more marked for paternal than maternal family history of cancer,
given that mothers were interviewed. However, the ORs associated with the paternal and maternal histories were very similar for HL and NHL. This may suggest that the recall bias was weak for lymphomas. Differences were observed for leukemia only, but there would appear to be no obvious reason for a recall bias for leukemia and not for lymphoma.
Five previous case-control studies have estimated the association between childhood leukemia and family history of cancer [14] [15] [16] [17] [18] . Cancer Registry data with a family database [8] [9] [10] [11] [12] [13] . One of these studies only addressed childhood acute lymphoblastic leukemia 9 and another, acute myeloblastic leukemia Hodgkin's and non-Hodgkin's lymphoma. The association with family history of cancer was always stronger for lymphoma than for leukemia, with observed standardized incidence rate ratio ranging from 1.0 to 1.8. Le Bihan et al. 35 did not observe an increased frequency of cancer in the relatives of children with non-Hodgkin's lymphoma in a familial study.
With regard to associations with specific types of malignancy in relatives, the literature is relatively heterogeneous and chance may explain some of the associations. Significant positive associations between childhood acute leukemia and a family history of cancer in the following disease sites was observed: oral cavity 16 ; esophagus or stomach 17 , colon 16, 17 , uterus or ovary 16 ; breast 18 ; brain 16 ; melanoma 17 ; testis 9 ; and kidney 12 . Childhood lymphoma, taken as a whole, was shown to be significantly associated with a family history of any lymphoma 10, 11 and brain tumor 12 .
In conclusion, our results support the hypothesis of a familial susceptibility to childhood lymphoma but not to childhood leukemia. Besides genetic factors, they may also reflect the existence of environmental or infectious risk factors shared by the family members.
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